Movement Alert|Salesforce.com Falls 3.06% in Pre-Market Trading, Morgan Stanley Slashes Target Price to $185 and Downgrades Rating

Market Focus
Jul 30

On July 30, Salesforce.com fell 3.06% in pre-market trading, trading at approximately $182.5 per share, with turnover of $3.3747 million. The decline was triggered by a wave of investment bank downgrades led by Morgan Stanley.

Morgan Stanley dramatically cut its target price on Salesforce.com from $287 to $185, a reduction exceeding 35%, while simultaneously downgrading its rating from Overweight to Equal-weight. Analyst Adam Wood noted that while the company's AI agent product Agentforce demonstrates strong key performance indicators, legacy business weakness continues to offset AI-driven incremental gains, leaving no visible inflection point in overall organic revenue or current remaining performance obligation growth trajectories. Bernstein also downgraded Salesforce.com to Market Perform, while Barclays lowered its target price to $236, creating a confluence of bearish signals.

Notably, Salesforce.com had risen over 3% in the prior session on sector rotation into SaaS software stocks — a move partly supported by Morgan Stanley's bullish stance on software names — making the reversal particularly sharp. The current stock price now sits near Morgan Stanley's revised $185 target.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10